Recent Advances in the Design and Synthesis of c-Met Inhibitors as Anticancer Agents (2014-Present).
Sign Up to like & getrecommendations! Published in 2017 at "Current medicinal chemistry"
DOI: 10.2174/0929867323666161028161441
Abstract: c-Met, also known as the surface receptor of hepatocyte growth factor receptor (HGFR), is a receptor tyrosine kinase with heterodimer transmembrane. c-Met involves in the activation of several signaling pathways, most of them are implicated… read more here.
Keywords: design synthesis; synthesis met; met inhibitors; recent advances ... See more keywords